Moreover, after integrating PD-L1 blockade with NCP@pyrolipid, tumor regression was observed in both light-irradiated primary tumors and distant tumors without light-irradiation, indicating that a potent tumor-specific immunity was evoked. Here, CD274 is linked to neoplasm.